<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifteen patients (nine male, six female) with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) undergoing HLA-identical allogeneic bone marrow transplantation (BMT) received preparative regimens consisting of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and total lymphoid irradiation </plain></SENT>
<SENT sid="1" pm="."><plain>Patients were aged from eight to 26 years (median 15 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Prophylaxis of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (GVHD) including <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and short course <z:chebi fb="0" ids="44185">methotrexate</z:chebi> was administered </plain></SENT>
<SENT sid="3" pm="."><plain>One early <z:hpo ids='HP_0011420'>death</z:hpo> occurred at day 8 post BMT </plain></SENT>
<SENT sid="4" pm="."><plain>Among the other 14 patients, one died of <z:hpo ids='HP_0100806'>sepsis</z:hpo> at day 53 with no evidence of engraftment, 13 were engrafted despite the number of donors exposed in transfusions of previous blood components </plain></SENT>
<SENT sid="5" pm="."><plain>Eleven patients have survived from six to 100 months (median, 54 months), post BMT </plain></SENT>
<SENT sid="6" pm="."><plain>The remaining two patients died of <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD-related <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> on days 44 and 63 </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> GVHD occurred among eight of 13 engrafted patients, five of whom were grades II-IV clinically </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> GVHD developed among five patients, three of whom were clinically progressive and extensive </plain></SENT>
<SENT sid="9" pm="."><plain>Two of three patients with extensive <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD had received transfusion of donor's buffy coat after BMT </plain></SENT>
<SENT sid="10" pm="."><plain>Our data indicate an engraftment rate of 87% (13/15) </plain></SENT>
<SENT sid="11" pm="."><plain>The projected probability of disease-free survival was 73% (11/15) at 9.3 years after BMT according to the Kaplan-Meier model </plain></SENT>
<SENT sid="12" pm="."><plain>Further efforts must be made to eliminate GVHD and to control fatal <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
</text></document>